Patents by Inventor Mark R. Green

Mark R. Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5941434
    Abstract: A holder/carrier temporarily attaches to and supports small items of multiple configurations. Using multiple, flexible straps that are each attached to a support base, the item is enwrapped and retained against the support base. An attachment mechanism, such as a retaining clip, is affixed to the support base, and is utilized to selectively attach the support base, along with the carried, enwrapped item, to a separate supporting structure, such as a waistband, belt or other, suitably-shaped, receiving structures. Additionally, by securing an attachment device that is cooperative with the support base attachment mechanism to another support surface, whether on a permanent or temporary basis, the attachment mechanism may be attached to support surfaces that would not otherwise be suitable.
    Type: Grant
    Filed: October 8, 1997
    Date of Patent: August 24, 1999
    Inventor: Mark R. Green
  • Patent number: 5766888
    Abstract: Methods are provided for detecting carcinoma metastases in selected body tissues and fluids. These methods offer greater than 1,000-fold enhanced sensitivity compared to prior standard diagnostic methods. In one embodiment of the invention, target carcinoma associated nucleic acid sequences are identified for detecting minimal residual disease in lung carcinomas. The methods utilize nucleic acid amplification techniques, preferably, the polymerase chain reaction.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: June 16, 1998
    Assignees: Roche Molecular Systems, Inc., The University of California
    Inventors: Robert E. Sobol, Mark R. Green, Ernest S. Kawasaki
  • Patent number: 5543296
    Abstract: Methods are provided for detecting carcinoma metastases in selected body tissues and fluids. These methods offer greater than 1,000-fold enhanced sensitivity compared to prior standard diagnostic methods. In one embodiment of the invention, target carcinoma associated nucleic acid sequences are identified for detecting minimal residual disease in lung carcinomas. The methods utilize nucleic acid amplification techniques, preferably, the polymerase chain reaction.
    Type: Grant
    Filed: December 16, 1994
    Date of Patent: August 6, 1996
    Assignees: Hoffman-La Roche Inc., Regents of the University of California
    Inventors: Robert E. Sobol, Mark R. Green, Ernest S. Kawasaki